Trial Profile
A Study of the Histopathological Changes within Ectopic Endometrial Tissue, in Subjects with Known Pelvic Endometriosis Following Treatment with Ulipristal Acetate, a Selective Progesterone Receptor Modulator (SPRM).
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Apr 2015
Price :
$35
*
At a glance
- Drugs Ulipristal (Primary)
- Indications Endometriosis
- Focus Therapeutic Use
- 01 Apr 2015 New trial record